Wall Street down for second straight day; energy weak
DJ: 18,011.14 -104.90 NAS: 4,994.73
-16.25 S&P: 2,091.50
-12.92
NEW YORK
(Reuters) - U.S. stocks fell for a second straight session
on Tuesday, with equities maintaining a tight range that corresponded with
currency fluctuations as traders focused on the dollar's strength and its
possible effect on corporate earnings.
Data from home sales to inflation and manufacturing
indicated the U.S. economy remains strong, but failed to alter expectations of a
faster or steeper monetary policy tightening path at the Federal Reserve.
Traders have honed in
on how the Fed will react to economic data, as a June interest rate increase
remains a possibility. Stocks have been inversely correlated to the U.S. dollar
and several multinational companies have given earnings forecasts that cited a
negative impact from a strong greenback.
"I don’t think there is a
tremendous amount of trepidation about earnings season. We will clearly
see the impact of lower energy prices as well as the stronger dollar,"
said David Lefkowitz, Senior Equity Strategist at UBS in New York.
"Those two
factors are fairly well-known, so I don’t expect it is going to be much in the
way of a surprise for most companies when they do report earnings, but clearly
those temporary factors are going to weigh on the growth for the first
quarter."
The S&P energy
index .SPNY lost 0.8 percent as Brent crude LCOc1 settled down 1.5 percent at
$55.11 a barrel after the dollar gained ground against the euro EUR=. The dollar index .DXY zigzagged between gains and losses
against a basket of major currencies and was up 0.14 percent on the day.
The Dow Jones industrial average .DJI fell 104.9 points, or
0.58 percent, to 18,011.14, theS&P 500 .SPX lost 12.92 points, or
0.61 percent, to 2,091.5 and the Nasdaq Composite .IXICdropped
16.25 points, or 0.32 percent, to 4,994.73.
Declines on the Nasdaq were tempered by a boost from Google (GOOGL.O), up 2.2 percent to $577.54. Morgan Stanley's (MS.N) chief financial officer is leaving the bank to join Google.
Biotechs were down for
a second straight session, pulled lower by a 2.4 percent drop in Biogen (BIIB.O) to $452.71. The Nasdaq biotech index .NBI is down 2.9 percent
in the past two sessions after snapping an eight-day winning streak.
Whiting Petroleum Corp
(WLL.N) plunged 19.5 percent to $30.91. North Dakota's largest oil
producer announced an offering of 35 million shares and a $1.75 billion mix of
notes and convertible notes to help cut its near-$6 billion debt load.
Volume was light, with about 5.29 billion shares traded on U.S. exchanges, below the
6.8 billion average so far this month, according to BATS Global Markets.
Declining issues
outnumbered advancing ones on the NYSE by 1,708 to 1,317, for a 1.30-to-1
ratio; on the Nasdaq, 1,415
issues fell and 1,284 advanced, for a 1.10-to-1 ratio favoring decliners.
The S&P 500 posted 22 new 52-week highs and 1 new
low; the Nasdaq Composite recorded 104 new highs and
22 new lows.
No comments:
Post a Comment